Home
Conditions
Leukemia, Myeloid, Acute

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,461 public trials 543 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Not Yet Recruiting

Azacitidine Combined with Donor Lymphocyte Infusion for Acute Myeloid Leukemia Post-transplant Relapse Prevention.

NCT06754540

Conditions: Acute Myeloid Leukemia (AML), Disease Attributes, Hematologic Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Avapritinib Maintenance for AML With KIT Mutations

NCT06765915

Conditions: AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Ruijin Hospital of Shanghai Jiaotong University Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Selinexor Combined With Venetoclax Maintenance Therapy After Allo-HSCT

NCT06765928

Conditions: AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Ruijin Hospital of Shanghai Jiaotong University Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML

NCT06763666

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia

NCT06702098

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Guangzhou Ruixin Biotechnology Co., Ltd Guangzhou, Guangdong Province, China, China

View Trial Details

Not Yet Recruiting

Molecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid Leukemia

NCT06652685

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China

View Trial Details

Not Yet Recruiting

A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined with Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.

NCT06641648

Conditions: Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia (AML) Relapse, Disease Attributes, +11 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

VA as Maintenance Therapy Post Allo-HSCT in MDS and AML

NCT06598384

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Twice-per-weekSelinexor, 2 Days Melphalan

NCT06613035

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Hebei Medical University Second Hospital Shijiazhuang, Hebeisheng, China

Zhengzhou University First Affiliated Hospital Zhengzhou, Henan, China

The 960th Hospital of the Joint Service Support Force of the Chinese People's Liberation Army Jinan, Shandong, China

People's Liberation Army The General Hospital of Western Theater Command Chengdu, Sichuan, China

View Trial Details

Not Yet Recruiting

TMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia.

NCT06602323

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: Not specified

View Trial Details

Leukemia, Myeloid, Acute

Leukemia, Myeloid, Acute trial results

Related conditions